» Articles » PMID: 31431177

Is Cell Migration a Selectable Trait in the Natural Evolution of Cancer Development?

Overview
Specialty Biology
Date 2019 Aug 22
PMID 31431177
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Selective evolutionary pressure shapes the processes and genes that enable cancer survival and expansion in a tumour-suppressive environment. A distinguishing lethal feature of malignant cancer is its dissemination and seeding of metastatic foci. A key requirement for this process is the acquisition of a migratory/invasive ability. However, how the migratory phenotype is selected for during the natural evolution of cancer and what advantage, if any, it might provide to the growing malignant cells remain open issues. In this opinion piece, we discuss three possible answers to these issues. We will examine lines of evidence from mathematical modelling of cancer evolution that indicate that migration is an intrinsic selectable property of malignant cells that directly impacts on growth dynamics and cancer geometry. Second, we will argue that migratory phenotypes can emerge as an adaptive response to unfavourable growth conditions and endow cells not only with the ability to move/invade, but also with specific metastatic traits, including drug resistance, self-renewal and survival. Finally, we will discuss the possibility that migratory phenotypes are coincidental events that emerge by happenstance in the natural evolution of cancer. This article is part of a discussion meeting issue 'Forces in cancer: interdisciplinary approaches in tumour mechanobiology'.

Citing Articles

Direct antitumoral effects of sulfated fucans isolated from echinoderms: a possible role of neuropilin-1/β1 integrin endocytosis and focal adhesion kinase degradation.

Lima A, Mignone V, Vardiero F, Kozlowski E, Fernandes L, Motta J Glycobiology. 2023; 33(9):715-731.

PMID: 37289485 PMC: 10627248. DOI: 10.1093/glycob/cwad044.


Evolution of multicellularity by collective integration of spatial information.

Colizzi E, Vroomans R, Merks R Elife. 2020; 9.

PMID: 33064078 PMC: 7652420. DOI: 10.7554/eLife.56349.


The forces of cancer.

Bakal C, Sero J Philos Trans R Soc Lond B Biol Sci. 2019; 374(1779):20190103.

PMID: 31431173 PMC: 6627019. DOI: 10.1098/rstb.2019.0103.

References
1.
Davidson S, Jonas O, Keibler M, Hou H, Luengo A, Mayers J . Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors. Nat Med. 2016; 23(2):235-241. PMC: 5407288. DOI: 10.1038/nm.4256. View

2.
Cheung K, Gabrielson E, Werb Z, Ewald A . Collective invasion in breast cancer requires a conserved basal epithelial program. Cell. 2013; 155(7):1639-51. PMC: 3941206. DOI: 10.1016/j.cell.2013.11.029. View

3.
Curto M, Cole B, Lallemand D, Liu C, McClatchey A . Contact-dependent inhibition of EGFR signaling by Nf2/Merlin. J Cell Biol. 2007; 177(5):893-903. PMC: 2064288. DOI: 10.1083/jcb.200703010. View

4.
Schito L, Semenza G . Hypoxia-Inducible Factors: Master Regulators of Cancer Progression. Trends Cancer. 2017; 2(12):758-770. DOI: 10.1016/j.trecan.2016.10.016. View

5.
Aceto N, Bardia A, Miyamoto D, Donaldson M, Wittner B, Spencer J . Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014; 158(5):1110-1122. PMC: 4149753. DOI: 10.1016/j.cell.2014.07.013. View